AFP and hepatocellular carcinoma: The median levels (interquartile range) of both PIVKA-II and AFP were significantly higher in the HCC group compared to the LC group and the NCHR group [1170.1 (29,863) mAU/mL vs. 26.5 (13.9) mAU/mL vs. 26.4 (6.8) mAU/mL for PIVKA-II, 65.5 (1986.7) ng/mL vs. 2.8 (3.7) ng/mL vs. 3.1 (2.2) ng/mL for AFP, all p < 0.001].